$19.80
5.71% today
Nasdaq, Feb 28, 04:02 pm CET
ISIN
US98978N2009
Symbol
ZIVO
Sector
Industry

Zivo Bioscience Inc Stock price

$21.00
+4.00 23.53% 1M
+10.00 90.91% 6M
-0.50 2.33% YTD
+12.40 144.19% 1Y
-0.30 1.41% 3Y
-54.60 72.22% 5Y
-26.52 55.81% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+1.04 5.21%
ISIN
US98978N2009
Symbol
ZIVO
Sector
Industry

Key metrics

Market capitalization $78.50m
Enterprise Value $78.72m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 984.00
P/S ratio (TTM) P/S ratio 981.25
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 398.55%
Revenue (TTM) Revenue $80.00k
EBIT (operating result TTM) EBIT $-13.66m
Free Cash Flow (TTM) Free Cash Flow $-4.12m
Cash position $160.00k
EPS (TTM) EPS $-4.87
P/E forward negative
P/S forward 552.82
EV/Sales forward 554.37
Short interest 2.61%
Show more

Is Zivo Bioscience Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Zivo Bioscience Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Zivo Bioscience Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Zivo Bioscience Inc:

Buy
100%

Financial data from Zivo Bioscience Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.08 0.08
300% 300%
100%
- Direct Costs 0.05 0.05
29% 29%
63%
0.03 0.03
150% 150%
38%
- Selling and Administrative Expenses 10 10
66% 66%
13,100%
- Research and Development Expense 3.20 3.20
103% 103%
4,000%
-14 -14
72% 72%
-17,075%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -14 -14
71% 71%
-17,078%
Net Profit -14 -14
61% 61%
-17,113%

In millions USD.

Don't miss a Thing! We will send you all news about Zivo Bioscience Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zivo Bioscience Inc Stock News

Neutral
Business Wire
22 days ago
TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces plans for a second collaborative study with the University of Delaware. This new study aims to further explore the potential applications of ZIVO's proprieta...
Neutral
Business Wire
about one month ago
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J. Management will deliver a corporat...
Neutral
Business Wire
2 months ago
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today provided an update on activities related to licensing its product targeting coccidiosis in broiler chickens. Following the announcement in August 202...
More Zivo Bioscience Inc News

Company Profile

Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.

Head office United States
CEO John Payne
Employees 8
Founded 1983
Website www.zivobioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today